What is the Impact Factor of Breast Cancer Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Breast Cancer Research is 6.20, ranking in quartile Q1 of Web of Science (SCIE).

Is Breast Cancer Research indexed in Web of Science or Scopus?

Yes, Breast Cancer Research is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.907 (Q1) and an H-index of 186.

Who publishes Breast Cancer Research and what is the Article Processing Charge (APC)?

Breast Cancer Research is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $3,871 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Breast Cancer Research?

The official ISO-4 abbreviation of Breast Cancer Research is "BREAST CANCER RES" with common acronym "brcr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,579Gold OA

Breast Cancer Research

Acronym:brcr

•

Abbreviation (ISO):BREAST CANCER RES

•

Identifier (ISSN):1465-5411(Print)/1465-542X(Online)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

6.2↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Breast Cancer Research

WoS Q1

Annual Impact Factor Metric

Current (2026):6.2

Scopus SJR & RankScopus Q1

1.907

#1,579

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

186

186 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate1.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

108articles/year

100% Gold OA•92.71% Original Research

Aims & Scope

Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.

Topics Covered (Recognized by AI)

Medicine99.5%Internal medicine98.2%Biology96.1%Genetics95%Cancer90.1%Breast cancer85.3%Oncology70.9%Surgery67.5%Surgical oncology60.3%Chemistry55.9%Biochemistry53.9%Pathology45%Cancer research42.1%Gene38.7%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank60/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank59/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	60/333	Q1
ONCOLOGY	JCISCIE	59/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF6.2

Articles / Year187

Total Citations58

2025

IF5.6

Articles / Year249

Total Citations1,119

2024

IF6.1

Articles / Year193

Total Citations2,371

2023

IF7.4

Articles / Year155

Total Citations3,105

2022

IF8.408

Articles / Year101

Total Citations2,741

Year	Impact Factor	Articles / Year	Total Citations
2026	6.2	187	58
2025	5.6	249	1,119
2024	6.1	193	2,371
2023	7.4	155	3,105
2022	8.408	101	2,741
2021	6.466	120	4,341
2020	4.988	138	8,964
2019	—	157	9,408
2018	—	156	7,902
2017	—	135	8,828
2016	—	132	10,409
2015	—	200	12,040

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,579Scopus Q1SCImago Profile

Scopus Coverage:1999-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.907

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.97

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,871 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,675

3-Year Documents430

Citable Documents426

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Breast Cancer Research (acronym: brcr, abbr: BREAST CANCER RES, ISSN: 1465-5411) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 1999. The periodical holds a Journal Impact Factor (JIF) of 6.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.907 (Q1), an H-index of 186.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 108 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,871 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.